 |
.
 |
News and Press Releases |
 |
SCHOTT presents new cartridge design specifically for high-speed filling lines
NEW YORK —April 23,
2013—At the pharmaceutical trade fair Interphex in New York, SCHOTT
Pharmaceutical Systems will be presenting the world’s first cartridges that
have been developed specifically for the use on high-speed filling lines. The
new design enables quicker processing and reduced overfill losses.
More info >> |
|
.
 |
White Papers |
 |
|
Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections
IBT Bioservices
Introduction
Staphylococcus aureus (SA) is a ubiquitous, formidable
Gram-positive pathogen associated with skin and soft tissue, as well as
lifethreatening systemic infections. SA is a leading cause of hospital- and
community-associated infections worldwide, affecting humans and animals. The
wide range of pathologies reflects the diverse abilities of this microbe to
escape the innate and adaptive immune response using virulence factors. Since
its first emergence in the 1960s methicillin-resistant SA (MRSA) has become
endemic in hospitals and healthcare settings worldwide. In the 1990s, community
associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a
major global challenge.
More info >> |
|
 |
Industry Events |
 |
3rd Annual Disruptive Innovations to Advance Clinical Trials
19-20 September 2013, The Fairmont Copley Plaza in Boston
Led
by Pfizer, Novartis, and Janssen this groundbreaking conference delivers only
disruptive approaches, models and technologies to change the pace of clinical
trials.
More info >> |
|
|
